Orbis Allan Gray’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-251,860
Closed -$49M – 58
2018
Q4
$49M Sell
251,860
-11,591
-4% -$2.26M 0.35% 35
2018
Q3
$54.6M Buy
263,451
+279
+0.1% +$55K 0.31% 37
2018
Q2
$48.6M Sell
263,172
-120
-0% -$21.2K 0.27% 39
2018
Q1
$44.9M Sell
263,292
-36,734
-12% -$6.74M 0.26% 42
2017
Q4
$52.2M Buy
300,026
+39
+0% +$6.9K 0.31% 38
2017
Q3
$55.9M Buy
299,987
+46,639
+18% +$8.26M 0.35% 40
2017
Q2
$43.6M Buy
+253,348
New +$41.2M 0.27% 42
2016
Q2
– Sell
-76,942
Closed -$11.5M – 79
2016
Q1
$11.5M Sell
76,942
-1,066,694
-93% -$158M 0.09% 63
2015
Q4
$186M Buy
1,143,636
+175,127
+18% +$27.5M 1.45% 20
2015
Q3
$134M Sell
968,509
-208,204
-18% -$32.8M 1.14% 26
2015
Q2
$181M Sell
1,176,713
-272,599
-19% -$43.7M 1.37% 21
2015
Q1
$232M Sell
1,449,312
-293,006
-17% -$46.1M 1.85% 16
2014
Q4
$278M Buy
1,742,318
+376,445
+28% +$58.7M 2.11% 16
2014
Q3
$192M Buy
1,365,873
+19,074
+1% +$2.49M 1.52% 22
2014
Q2
$159M Buy
1,346,799
+63,534
+5% +$7.35M 1.31% 27
2014
Q1
$158M Buy
+1,283,265
New +$156M 1.26% 30

Other funds holding AMGN

Orbis Allan Gray's AMGN Position: Q1 2019 in Review

Orbis Allan Gray sold out of Amgen (AMGN) in Q1 2019, closing a stake of 251,860 shares — an estimated $49M sold.

Orbis Allan Gray first reported a position in AMGN in Q1 2014 and held it in 16 quarters. The position peaked at $278M in Q4 2014. 1,881 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Orbis Allan Gray reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Orbis Allan Gray sold 251,860 Amgen shares in Q1 2019, an estimated $49M.
  • Orbis Allan Gray first reported a position in Amgen in Q1 2014 and held it in 16 quarters.
  • Orbis Allan Gray's Amgen position peaked at $278M in Q4 2014.
  • 1,881 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Orbis Allan Gray's 13F filing for Q1 2019, filed 15 May 2019.